Intermittent high glucose enhances cell proliferation and VEGF expression in retinal endothelial cells: The role of mitochondrial reactive oxygen species

Molecular and Cellular Biochemistry

Volumn 343, Issue 1-2, 2010, Pages 27-35

  Sun, Jiazhong ^a   Xu, Yancheng ^a   Sun, Suxin ^a   Sun, Yanlei ^a   Wang, Xiang ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Cell proliferation; Diabetic retinopathy; Intermittent high glucose; Oxidative stress; VEGF

Indexed keywords

3 NITROTYROSINE; 8 HYDROXYDEOXYGUANOSINE; DNA; GLUCOSE; MANGANESE DERIVATIVE; MESSENGER RNA; METALLOPORPHYRIN; REACTIVE OXYGEN METABOLITE; THENOYLTRIFLUOROACETONE; THYMIDINE; TRITIUM; VASCULOTROPIN;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HYPERGLYCEMIA; MITOCHONDRION; NORTHERN BLOTTING; OXIDATIVE STRESS; PROTEIN CONTENT; RETINA;

BLOTTING, NORTHERN; CELL PROLIFERATION; CELLS, CULTURED; DEOXYGUANOSINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLUCOSE; HUMANS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RETINA; TYROSINE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77957596253     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-010-0495-5     Document Type: Article

References (40)

1. R Klein BE Klein SE Moss MD Davis DL DeMets 1984 The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years Arch Ophthalmol 102 520 526 1:STN:280:DyaL2c7ltlCksQ%3D%3D 6367724 (Pubitemid 14127838)
2. AK Sjolie J Stephenson S Aldington E Kohner H Janka L Stevens J Fuller 1997 Retinopathy and vision loss in insulin-dependent diabetes in Europe. The EURODIAB IDDM complications study Ophthalmology 104 252 260 1:STN:280: DyaK2s3gsFWhsA%3D%3D 9052629
3. JW Miller AP Adamis LP Aiello 1997 Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy Diabetes Metab Rev 13 37 50 1:CAS:528:DyaK2sXjt1Gks7s%3D 10.1002/(SICI)1099-0895(199703)13: 1<37::AID-DMR174>3.0.CO;2-K 9134347 (Pubitemid 27213792)
4. V Simorre-Pinatel M Guerrin P Chollet M Penary S Clamens F Malecaze J Plouet 1994 Vasculotropin-VEGF stimulates retinal capillary endothelial cells through an autocrine pathway Invest Ophthalmol Vis Sci 35 3393 3400 1:STN:280:DyaK2czjsVSitQ%3D%3D 8056513
5. E Duh LP Aiello 1999 Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox Diabetes 48 1899 1906 1:CAS:528: DyaK1MXmsVequ7c%3D 10.2337/diabetes.48.10.1899 10512352 (Pubitemid 29458350)
6. M Brownlee 2001 Biochemistry and molecular cell biology of diabetic complications Nature 414 813 820 1:CAS:528:DC%2BD38Xhtlyltg%3D%3D 10.1038/414813a 11742414 (Pubitemid 34000785)
7. T Nishikawa D Edelstein XL Du S Yamagishi T Matsumura Y Kaneda MA Yoerk D Beebe PJ Oates HP Hammes, et al. 2000 Normalizing mitochondrial superoxide production blocks three pathways of hyperglycemic damage Nature 404 787 790 1:CAS:528:DC%2BD3cXjtVals70%3D 10.1038/35008121 10783895 (Pubitemid 30212409)
8. RA Kowluru J Tang TS Kern 2001 Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy Diabetes 50 1938 1942 1:CAS:528:DC%2BD3MXlslKms78%3D 10.2337/diabetes.50.8.1938 11473058
9. RA Kowluru RL Engerman TS Kern 2000 Abnormalities of retinal metabolism in diabetes or experimental galactosemia VIII. Prevention by aminoguanidine Curr Eye Res 21 814 819 1:STN:280:DC%2BD3M7gvVOiuw%3D%3D 10.1076/ceyr.21.4.814.5545 11120572 (Pubitemid 32099432)
10. M Kuroki EE Voest S Amano LV Beerepoot S Takashima M Tolentino RY Kim RM Rohan KA Colby KT Yeo AP Adamis 1996 Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo J Clin Invest 98 1667 1675 1:CAS:528:DyaK28XmtVClsrY%3D 10.1172/JCI118962 8833917
11. IG Obrosova AG Minchenko V Marinescu L Fathallah A Kennedy CM Stockert RN Frank MJ Stevens 2001 Antioxidants attenuate early up regulation of retinal vascular endothelial growth factor in streptozotocin-diabetic rats Diabetologia 44 1102 1110 1:CAS:528:DC%2BD3MXmtlWltr8%3D 10.1007/s001250100631 11596663 (Pubitemid 32835501)
12. R Klein 1995 Hyperglycemia and microvascular and macrovascular disease in diabetes Diabetes Care 18 258 268 1:STN:280:DyaK2M3ks1KjsQ%3D%3D 10.2337/diacare.18.2.258 7729308
13. L Monnier E Mas C Ginet F Michel L Villon JP Cristol C Colette 2006 Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes JAMA 295 1681 1687 1:CAS:528:DC%2BD28XjsVequ7k%3D 10.1001/jama.295.14.1681 16609090
14. JA Gimeno-Orna FJ Castro-Alonso B Boned-Juliani LM Lou-Arnal 2003 Fasting plasma glucose variability as a risk factor of retinopathy in type 2 diabetic patients J Diabetes Complicat 17 78 81 10.1016/S1056-8727(02)00197-6 12614973 (Pubitemid 36279504)
15. L Quagliaro L Piconi R Assaloni 2003 Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation Diabetes 52 2795 2804 1:CAS:528:DC%2BD3sXovVagtL0%3D 10.2337/diabetes.52.11.2795 14578299 (Pubitemid 37339710)
16. P Xia LP Aiello H Ishii ZY Jiang DJ Park GS Robinson ZY Jiang DJ Park GS Robinson ZY Jiang, et al. 1996 Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth J Clin Invest 98 2018 2026 1:CAS:528:DyaK28XmvVequr8%3D 10.1172/JCI119006 8903320
17. MJ Sheetz GL King 2002 Molecular understanding of hyperglycemia's adverse effects for diabetic complications JAMA 288 2579 2588 1:CAS:528: DC%2BD38XptFOgsrw%3D 10.1001/jama.288.20.2579 12444865 (Pubitemid 35386893)
18. GL King M Brownlee 1996 The cellular and molecular mechanisms of diabetic complications Endocrinol Metab Clin North Am 25 255 270 1:CAS:528: DyaK28XksFShsrs%3D 10.1016/S0889-8529(05)70324-8 8799700 (Pubitemid 26195621)
19. AS De Vriese TJ Verbeuren J Van de Voorde NH Lameire PM Vanhoutte 2000 Endothelial dysfunction in diabetes Br J Pharmacol 130 963 974 10.1038/sj.bjp.0703393 10882379
20. U Hink H Li H Mollnau M Oelze E Matheis M Hartmann M Skatchkov F Thaiss RA Stahl A Warnholtz, et al. 2001 Mechanisms underlying endothelial dysfunction in diabetes mellitus Circ Res 88 E14 E22 1:CAS:528:DC%2BD3MXhtVaitrg%3D 11157681
21. JR Williamson C Kilo 1983 Capillary basement membrane in diabetes Diabetes 32 96 100 6400674
22. PA D'Amore 1994 Mechanisms of retinal and choroidal neovascularization Invest Ophthalmol Vis Sci 35 3974 3979 7525506
23. MM Sholley GP Ferguson HR Seibel JL Montour JD Wilson 1984 Mechanisms of neovascularization. Vascular sprouting can occur without proliferation of endothelial cells Lab Invest 51 624 634 1:STN:280:DyaL2M%2FlvFamtw%3D%3D 6209468
24. AN Witmer GF Vrensen CJ Van Noorden RO Schlingemann 2003 Vascular endothelial growth factors and angiogenesis in eye disease Prog Retin Eye Res 22 1 29 1:CAS:528:DC%2BD3sXht1Cqsb0%3D 10.1016/S1350-9462(02)00043-5 12597922 (Pubitemid 36207453)
25. RF Gariano TW Gardner 2005 Retinal angiogenesis in development and disease Nature 438 960 966 1:CAS:528:DC%2BD2MXhtlSksrnP 10.1038/nature04482 16355161 (Pubitemid 43093962)
26. C Premanand M Rema MZ Sameer M Sujatha M Balasubramanyam 2006 Effect of curcumin on proliferation of human retinal endothelial cells under in vitro conditions Invest Ophthalmol Vis Sci 47 2179 2184 10.1167/iovs.05-0580 16639030 (Pubitemid 46768303)
27. ES Kilpatrick AS Rigby SL Atkin 2009 The effect of glucose variability on the long-term risk of microvascular complications in type 1 diabetes Diabetes Care 32 901 1903 10.2337/dc09-0109
28. ES Kilpatrick AS Rigby SL Atkin 2008 A1C variability and the risk of microvascular complications in type 1 diabetes: data from the Diabetes Control and Complications Trial Diabetes Care 31 L2198 L2202 10.2337/dc08-0864
29. SC Jones HJ Saunders W Qi CA Pollock 1999 Intermittent high glucose enhances cell growth and collagen synthesis in cultured human tubulointerstitial cells Diabetologia 42 1113 1119 1:CAS:528:DyaK1MXlsF2nt74%3D 10.1007/s001250051279 10447524 (Pubitemid 29408810)
30. A Takeuchi DC Throckmorton AP Brogden 1995 Periodic high extracellular glucose enhances production of collagens III and IV by mesangial cells Am J Physiol 268 F13 F19 1:CAS:528:DyaK2MXktFWntbg%3D 7840239
31. JR Singleton AG Smith JW Russell EL Feldman 2003 Microvascular complications of impaired glucose tolerance Diabetes 52 2867 2873 1:CAS:528:DC%2BD3sXpsFagsLw%3D 10.2337/diabetes.52.12.2867 14633845 (Pubitemid 37466854)
32. A Ceriello 1998 The emerging role of post-prandial hyperglycaemic spikes in the pathogenesis of diabetic complications Diabet Med 15 188 193 1:STN:280:DyaK1c3gsVKkuw%3D%3D 10.1002/(SICI)1096-9136(199803)15:3<188::AID- DIA545>3.0.CO;2-V 9545118 (Pubitemid 28126152)
33. S Chakrabarti M Cukiernik D Hileeto T Evans S Chen 2000 Role of vasoactive factors in the pathogenesis of early changes in diabetic retinopathy Diabetes Metab Res Rev 16 393 407 1:CAS:528:DC%2BD3MXoslyntQ%3D%3D 10.1002/1520-7560(0000)9999:9999<::AID-DMRR157>3.0.CO;2-G 11114100 (Pubitemid 32066547)
34. T Sanchez-Elsner LM Botella B Velasco A Corbi L Attisano C Bernabeu 2001 Synergistic cooperation between hypoxia and transforming growth factor-beta pathways on human vascular endothelial growth factor gene expression J Biol Chem 276 38527 38535 1:CAS:528:DC%2BD3MXnvVensbg%3D 10.1074/jbc.M104536200 11486006
35. HP Hammes J Lin RG Bretzel M Brownlee G Breier 1998 Upregulation of the vascular endothelial growth experimental background diabetic retinopathy of the rat Diabetes 47 401 406 1:CAS:528:DyaK1cXhs1aqtbk%3D 10.2337/diabetes.47.3.401 9519746 (Pubitemid 28104202)
36. RE Gilbert D Vranes JL Berka DJ Kelly A Cox LL Wu SA Stacker ME Cooper 1998 Vascular endothelial growth factor and its receptors in control and diabetic rat eyes Lab Invest 78 1017 1027 1:CAS:528:DyaK1cXlslWqsLo%3D 9714188
37. M Balasubramanyam M Rema C Premanand 2002 Biochemical and molecular mechanisms of diabetic retinopathy Curr Sci 83 1506 1514 1:CAS:528: DC%2BD3sXhtVGisb8%3D
38. A El-Osta D Brasacchio D Yao A Pocai PL Jones RG Roeder ME Cooper M Brownlee 2008 Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia J Exp Med 205 2409 2417 1:CAS:528:DC%2BD1cXht1SrtLnN 10.1084/jem.20081188 18809715
39. SE Siegelaar F Holleman JB Hoekstra JH DeVries 2010 Glucose variability: does it matter? Endocr Rev 31 171 182 1:CAS:528:DC%2BC3cXmtlSgs74%3D 10.1210/er.2009-0021 19966012
40. L Nalysnyk M Hernandez-Medina G Krishnarajah 2010 Glycaemic variability and complications in patients with diabetes mellitus: evidence from a systematic review of the literature Diabetes Obes Metab 12 288 298 1:STN:280: DC%2BC3c3lt1egsA%3D%3D 10.1111/j.1463-1326.2009.01160.x 20380649